Description
A malignancy arising in uterine cervical epithelium and confined thereto, representing a continuum of histological changes ranging from well-differentiated CIN 1 (formerly, mild dysplasia) to severe dysplasia/carcinoma in situ, CIN 3. The lesion arises at the squamocolumnar cell junction at the transformation zone of the endocervical canal, with a variable tendency to develop invasive epidermoid carcinoma, a tendency that is enhanced by concomitant human papillomaviral infection. (Segen, Dictionary of Modern Medicine, 1992) MeSH
Hierarchy View
Phase 4 Indicated Drugs (8)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (20)
Other Experimental Indicated Drugs (2)
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (29)
Organization Involved with Phase 2 Indications (71)
Gottfried Wilhelm Leibniz Universität Hannover
Greater Cincinnati OB/GYN, Inc.
Hoosier Cancer Research Network
IGO Medical Group of San Diego
Jersey Shore University Medical Center
Kharkov Academy of Postgraduate Education
Mount Vernon Clinical Research, LLC
National Academy of Medical Sciences of Ukraine
Northern California Research Corp
North Estonia Medical Centre Foundation
OB/GYN Specialists of the Palm Beaches
Odessa National Medical University
Physician Care Clinical Research LLC
Robin Black OGNP, Costa Mesa California
Shanghai Zhangjiang Biotechnology Limited Company
South Carolina Oncology Associates
Organization Involved with Phase 1 Indications (12)
Organization Involved with Other Experimental Indications (2)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
